Meridian Bioscience (VIVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 09-2017 | 09-2016 | 09-2015 | 09-2014 | 09-2013 | |
| Sales | 200,771 | 196,082 | 194,830 | 188,832 | 188,686 |
| Cost of Goods | 76,479 | 68,870 | 72,948 | 71,589 | 67,642 |
| Gross Profit | 124,292 | 127,212 | 121,882 | 117,243 | 121,044 |
| Operating Expenses | 87,389 | 76,704 | 66,770 | 65,440 | 64,372 |
| Operating Income | 37,382 | 51,378 | 56,060 | 52,392 | 57,314 |
| Interest Expense | 1,642 | 897 | 0 | 0 | 0 |
| Other Income | 689 | 163 | -997 | -284 | 48 |
| Pre-tax Income | 36,429 | 50,644 | 55,063 | 52,108 | 57,362 |
| Income Tax | 14,872 | 18,415 | 19,523 | 17,365 | 19,330 |
| Net Income Continuous | 21,557 | 32,229 | 35,540 | 34,743 | 38,032 |
| Net Income | $21,557 | $32,229 | $35,540 | $34,743 | $38,032 |
| EPS Basic Total Ops | 0.51 | 0.77 | 0.85 | 0.84 | 0.92 |
| EPS Basic Continuous Ops | 0.51 | 0.77 | 0.85 | 0.84 | 0.92 |
| EPS Diluted Total Ops | 0.51 | 0.76 | 0.85 | 0.83 | 0.91 |
| EPS Diluted Continuous Ops | 0.51 | 0.76 | 0.85 | 0.83 | 0.91 |
| EPS Diluted Before Non-Recurring Items | 0.67 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $53,100 | $59,096 | $62,669 | $59,656 | $64,466 |